We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Ultrasound Can Be Used as a Painless and Viable Alternative to Losing Weight

By HospiMedica International staff writers
Posted on 24 Feb 2015
Print article
Image: UltraShape Ultrasound Machine (Photo courtesy of Syneron Medical).
Image: UltraShape Ultrasound Machine (Photo courtesy of Syneron Medical).
A leading producer of aesthetic medical devices has developed the first noninvasive body contouring treatment approved by the United States Food and Drug Administration (FDA). Most women are unhappy about their abdominal area, and the new treatment offers a safe and efficient treatment for reducing abdominal fat by an average of 3.3–6.35 cm.

The treatment makes use of pulsed focused ultrasound to precisely target subcutaneous fat, without heating it, while keeping blood vessels, nerves, muscles and other surrounding tissue intact. The treatment does not require any surgery, anesthetics, or recovery time, and targets fat deposits that are difficult to remove with diet, and exercise alone.

The treatment was developed by Syneron Medical (Irvine, CA, USA) and is called UltraShape. The treatment destroys fat cells by emitting acoustic waves of ultrasonic energy, and focusing them into a confined focal volume. UltraShape transmits pulsed ultrasound, which restricts temperature elevation to less than 0.5 °C increase. The treatment targets only subcutaneous fat at a known depth, and destroys fat instantly, and selectively.

Shimon Eckhouse, PhD, Chairman of the Board of Directors for Syneron Candela, stated, "UltraShape uses ultrasound technology that was perfected in 10 years of research and development by world leading scientists and doctors to noninvasively destruct fat without any damage to surrounding tissue. UltraShape efficiency in noninvasive fat destruction has been studied and proven in more than 13 clinical studies with more than 900 patients treated by this technology. These studies have also demonstrated the excellent safety record of the technology as well as its ability to do it with no downtime to the patient."

Related Links:

Syneron Medical
Ultrashape 


New
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Manual Defibrillator
RESCUE 230
New
Flexible Examination Light
ri-magic LED
New
Capnograph/Pulse Oximeter
Handleld Capnograph/Pulse Oximeter

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Surgical Techniques

view channel
Image: Gut microbiota helps healing in colorectal cancer surgery (Photo courtesy of CRCHUM)

Modifying Intestinal Flora Before Surgery Reduces Postoperative Complications in Colorectal Cancer Patients

Up to 30% of all patients undergoing colorectal surgery suffer from serious complications due to poor healing of their intestinal barrier. Anastomotic complications cause inflammation, serious infection... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.